FI814132L - Kefalosporinderivat - Google Patents

Kefalosporinderivat

Info

Publication number
FI814132L
FI814132L FI814132A FI814132A FI814132L FI 814132 L FI814132 L FI 814132L FI 814132 A FI814132 A FI 814132A FI 814132 A FI814132 A FI 814132A FI 814132 L FI814132 L FI 814132L
Authority
FI
Finland
Prior art keywords
kefalosporinderivat
Prior art date
Application number
FI814132A
Other languages
English (en)
Finnish (fi)
Inventor
Frederic Henri Jung
Gareth Morse Davies
Original Assignee
Ici Pharma
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Pharma, Ici Plc filed Critical Ici Pharma
Publication of FI814132L publication Critical patent/FI814132L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D463/00Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16Nitrogen atoms
    • C07D463/18Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D463/00Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16Nitrogen atoms
    • C07D463/18Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D505/00Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
FI814132A 1980-12-22 1981-12-22 Kefalosporinderivat FI814132L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8027254A FR2496666A1 (fr) 1980-12-22 1980-12-22 Nouveaux derives de cephalosporine et composition pharmaceutique les contenant

Publications (1)

Publication Number Publication Date
FI814132L true FI814132L (fi) 1982-06-23

Family

ID=9249365

Family Applications (1)

Application Number Title Priority Date Filing Date
FI814132A FI814132L (fi) 1980-12-22 1981-12-22 Kefalosporinderivat

Country Status (15)

Country Link
US (1) US4492692A (fr)
EP (1) EP0055562B1 (fr)
JP (1) JPS57167991A (fr)
AU (1) AU7878681A (fr)
DE (1) DE3173789D1 (fr)
DK (1) DK572581A (fr)
ES (2) ES8304140A1 (fr)
FI (1) FI814132L (fr)
FR (1) FR2496666A1 (fr)
GR (1) GR76914B (fr)
IL (1) IL64512A0 (fr)
NO (1) NO814372L (fr)
PT (1) PT74173B (fr)
YU (2) YU303981A (fr)
ZA (1) ZA818594B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0071370A3 (fr) * 1981-07-23 1984-05-16 Ici Pharma Dérivés de céphalosporine, leur préparation et les compositions pharmaceutiques les contenant
US4504478A (en) * 1981-09-18 1985-03-12 Imperial Chemical Industries Plc Cephalosporin-1-oxide derivatives
EP0082648A3 (fr) * 1981-12-21 1984-09-26 Imperial Chemical Industries Plc Dérivés de céphalosporines
DK163000C (da) * 1982-09-30 1992-06-01 Shionogi & Co Analogifremgangsmaade til fremstilling af vinylthioacetamido-1-dethia-1-oxa-cephalosporinderivater
JPS59110695A (ja) * 1982-12-16 1984-06-26 Asahi Chem Ind Co Ltd 経口用セフアロスポリン
US4855420A (en) * 1983-06-03 1989-08-08 Ici Pharma Cephalosporin derivatives
US4547573A (en) * 1983-12-02 1985-10-15 Ici Pharma Process for preparing cephalosporin derivatives
US5817823A (en) * 1997-04-17 1998-10-06 Sepracor Inc. Method for synthesizing 2-substituted imidazoles
TW202345806A (zh) 2022-03-31 2023-12-01 美商艾伯維有限公司 噻唑并〔5,4-b〕吡啶malt-1抑制劑

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1032533A (fr) * 1973-09-07 1978-06-06 William H. Koster Procede de fabrication des composes de la cephalosporine
JPS55133355A (en) * 1979-04-03 1980-10-17 Shionogi & Co Ltd Inversion of 3-amino group of beta-lactam ring
EP0018595B1 (fr) * 1979-04-27 1986-08-20 Merck & Co. Inc. 7-N-Hétérocyclyl-céphalosporines, procédé pour leur préparation et composition pharmaceutique les contenant
US4358447A (en) * 1979-04-27 1982-11-09 Merck & Co., Inc. 7-N-Heterocyclyl cephalosporins
FR2472574A1 (fr) * 1979-12-24 1981-07-03 Ici Pharma Derives de cephalosporine et composition pharmaceutique les contenant

Also Published As

Publication number Publication date
ES508280A0 (es) 1983-02-16
YU45886B (sh) 1992-09-07
YU110983A (en) 1983-12-31
EP0055562A3 (en) 1982-08-11
ZA818594B (en) 1982-12-29
YU303981A (en) 1983-12-31
EP0055562B1 (fr) 1986-02-12
FR2496666A1 (fr) 1982-06-25
PT74173A (en) 1982-01-01
EP0055562A2 (fr) 1982-07-07
DE3173789D1 (en) 1986-03-27
IL64512A0 (en) 1982-03-31
ES8304140A1 (es) 1983-02-16
AU7878681A (en) 1982-07-01
GR76914B (fr) 1984-09-04
NO814372L (no) 1982-06-23
ES8307818A1 (es) 1983-08-16
US4492692A (en) 1985-01-08
PT74173B (en) 1983-05-17
JPS57167991A (en) 1982-10-16
DK572581A (da) 1982-06-23
ES517824A0 (es) 1983-08-16

Similar Documents

Publication Publication Date Title
BE887534A (fr) Sandwichpaneelelement
BE889577A (nl) Golfvormsynthese
BE891422A (fr) Degrilleur
BR8107326A (pt) Container-tanque
FI814132L (fi) Kefalosporinderivat
BR8101718A (pt) Microcentrais
BE889004A (nl) Grijper
BR8108640A (pt) Filatorio
BE889192A (fr) Recolteuse-hacheuse
DE3163961D1 (de) Heteroalkylene-bis-anthraquinones
BR8108621A (pt) Arpeu
BE889708A (fr) Sous-soleuse
BE890439A (fr) Afdekbaanrol
BE890703A (fr) Robinet-vanne
BE891654A (fr) Schuifdeur
FI810038L (fi) Rifamycinderivat
BE888818A (fr) Telerupteur
BE887835A (fr) Fluidumsysteem
JPS5736748A (ja) Riidoriree
AR219450A1 (es) Portasachet
FI801678A (fi) Stomme foer lysroersbelysningsanordning
BR8007025A (pt) Vagonete monotrilho
BR6000166U (pt) Dorramatico
BR8006091A (pt) Momicroencapsulacao
SE8002392L (sv) Kernborrmaskin

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: IMPERIAL CHEMICAL INDUSTRIES PLC

Owner name: ICI PHARMA